Results 61 to 70 of about 258,864 (309)

Canadian healthcare provider perspectives and practices in the provision of sexual health support for people with chronic kidney disease: a mixed methods study

BMC Nephrology
Background People with non-dialysis-dependent chronic kidney disease (CKD) have identified sexual health as an important aspect of kidney care and a research priority, yet limited information is available on how sexual health is provided within ...
Shannan Love, Sabrina Jassemi, Maoliosa Donald, Dwight Sparkes, Sandra Dumanski, Clare McKeaveney, Heather Beanlands, Janine Farragher, Lori Harwood, Joanne Kappel, Gillian Crysdale, Kaitlin Ahrenholz, Laurinda Ferreira, Maria Delgado, Nancy Verdin, Betty Pearson, Brenda R. Hemmelgarn, Meghan J. Elliott   +17 more
doaj   +1 more source

Update on the Burden of CKD [PDF]

Journal of the American Society of Nephrology, 2017
Recent studies confirm that the global burden of CKD is high but point to interesting trends and methodologic challenges. Data on CKD burden have grown dramatically over the past years, building on the foundation set by standardizing the definition and staging of CKD in 2002.
openaire   +2 more sources

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

A collaborative, individual-level analysis compared longitudinal outcomes across the International Network of Chronic Kidney Disease (iNETCKD) cohorts. [PDF]

, 2019
Rates of chronic kidney disease (CKD) progression, end stage kidney disease (ESKD), all-cause mortality, and cardiovascular (CVD) events among individuals with CKD vary widely across countries.
Djurdjev, Ognjenka, Wendy Hoy, Oh, K-H, Hoy, Wendy, Kook-Hwan Oh, Curie Ahn, Zaimin Wang, Go, Alan, Feldman, Harold I., Oh, Kook-Hwan, Cockwell, P, Sola, Laura, Wang, Zaimin, Lawrence Appel, iNET-CKD Collaborators, Pablo G. Rios, Naohiko Fujii, Mila Tang, Orlandi, Paula F., Anthony Fenton, Vivek Kumar, Vivekanand Jha, Ahn, Curie, Wendy E. Hoy, Fukagawa, Masafumi, Orlandi, Paula F, Levin, A, Jianzhen Zhang, Jha, Vivekanand, Jing Huang, Adeera Levin, Hoy, Wendy E., Huang, Jing, Paula F. Orlandi, Liliana Gadola, Alan Go, Takayuki Hamano, Appel, Lawrence, Han, Seung Hyeok, Hoy, W, Orlandi, PF, Fenton, Anthony, Lisa Nessel, Tang, Mila, Seung Hyeok Han, Helen G. Healy, Dong Wan Chae, Rios, Pablo G., Zhang, Jianzhen, Laura Sola, Ashok Kumar Yadav, Feldman, HI, Paul Cockwell, Harold I. Feldman, Feldman, Harold I, Sola, L, Levin, Adeera, Masafumi Fukagawa, Chae, Dong Wan, Nessel, Lisa, Fukagawa, M, Cockwell, Paul, Huang, J, Takahiro Imaizumi, Healy, Helen G., Ognjenka Djurdjev   +65 more
core   +1 more source

Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son, Inyoung Hwang, Sang Won Lee, Yun Kim   +3 more
wiley   +1 more source

Management of Osteoporosis in CKD [PDF]

Clinical Journal of the American Society of Nephrology, 2018
CKD mineral and bone disease is a common complication of kidney disease, and it affects the majority of patients with moderate to severe CKD. Recently, prospective studies have shown that measurement of bone mineral density by dual energy x-ray absorptiometry predicts incident fracture, providing nephrologists the ability to risk classify patients for ...
Pascale Khairallah, Thomas L. Nickolas
openaire   +2 more sources

EARLY DIAGNOSTIC AND PROGNOSTIC MARKERS OF CHRONIC KIDNEY DISEASE (CKD) IN CANINE AND FELINE PATIENTS [PDF]

, 2011
SUMMARY Chronic kidney disease (CKD) is a clinical syndrome with a high prevalence both in human and veterinary medicine. Being able to formulate an early diagnosis of CKD can allow veterinarians to introduce a dietary and medical therapy, which can ...
LIPPI, ILARIA
core  

CKD-mediated systemic effects on the neurohumoral and immune systems.

, 2018
Plasma levels of Angiotensin II (A); and Pro- and anti-inflammatory cytokine profile (B) in plasma samples of CKD rats (n = 3) compared to sham (n = 4).
Lena Cohen (4012094), Ann Saada (341104), Gad Keren (376640), Michal Entin-Meer (618054), Einat Bigelman (5367932), Zach Rozenbaum (5367935), Ran Levy (196173), Genya Aharon-Hananel (5367929)   +7 more
core   +1 more source

Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel, Fauzia Hollangel, Caroline Packee, Amita Kapoor, Brad Rovin, Nathalie Costedoat‐Chalumeau, Shivani Garg   +6 more
wiley   +1 more source

Clinical, Histologic, and Serological Predictors of Renal Function Loss in Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Kidney survival is the ultimate goal in lupus nephritis (LN) management, but long‐term predictors remain inadequately studied, requiring long‐term follow‐up. This study aimed to identify baseline and early longitudinal predictors of kidney survival in the Accelerating Medicines Partnership LN longitudinal cohort.
Shangzhu Zhang, Laurence Magder, Daniel Goldman, Judith A. James, Joel M. Guthridge, Carla Guthridge, Peter Izmirly, Jill P. Buyon, H. Michael Belmont, Richard A. Furie, Noa Schwartz, Chaim Putterman, Jennifer L. Barnas, Jennifer H. Anolik, Sarah French, Maria Dall'Era, Avi Z. Rosenberg, Jeffrey Hodgin, Dawit S. Demeke, the Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE) Network, Michelle Petri, Andrea Fava   +21 more
wiley   +1 more source